[
    [
        {
            "time": "2020-01-01",
            "original_text": "高瓴资本“生物医药”布局有何变化，投资逻辑究竟是啥？",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "生物医药",
                    "布局",
                    "投资逻辑"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "高瓴资本“生物医药”布局有何变化，投资逻辑究竟是啥？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]